• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-9/9在人类癌症中的多功能特性。

The versatile nature of miR-9/9 in human cancer.

作者信息

Nowek Katarzyna, Wiemer Erik A C, Jongen-Lavrencic Mojca

机构信息

Department of Hematology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

出版信息

Oncotarget. 2018 Apr 17;9(29):20838-20854. doi: 10.18632/oncotarget.24889.

DOI:10.18632/oncotarget.24889
PMID:29755694
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5945517/
Abstract

miR-9 and miR-9 (miR-9/9) were first shown to be expressed in the nervous system and to function as versatile regulators of neurogenesis. The variable expression levels of miR-9/9 in human cancer prompted researchers to investigate whether these small RNAs may also have an important role in the deregulation of physiological and biochemical networks in human disease. In this review, we present a comprehensive overview of the involvement of miR-9/9 in various human malignancies focusing on their opposing roles in supporting or suppressing tumor development and metastasis. Importantly, it is shown that the capacity of miR-9/9 to impact tumor formation is independent from their influence on the metastatic potential of tumor cells. Moreover, data suggest that miR-9/9 may increase malignancy of one cancer cell population at the expense of another. The functional versatility of miR-9/9 emphasizes the complexity of studying miRNA function and the importance to perform functional studies of both miRNA strands in a relevant cellular context. The possible application of miR-9/9 as targets for miRNA-based therapies is discussed, emphasizing the need to obtain a better understanding of the functional properties of these miRNAs and to develop safe delivery methods to target specific cell populations.

摘要

miR-9和miR-9(miR-9/9)最初被证明在神经系统中表达,并作为神经发生的多功能调节因子发挥作用。miR-9/9在人类癌症中的可变表达水平促使研究人员探究这些小RNA在人类疾病中生理和生化网络失调方面是否也发挥重要作用。在本综述中,我们全面概述了miR-9/9在各种人类恶性肿瘤中的作用,重点关注它们在支持或抑制肿瘤发展和转移方面的相反作用。重要的是,研究表明miR-9/9影响肿瘤形成的能力与其对肿瘤细胞转移潜能的影响无关。此外,数据表明miR-9/9可能以牺牲另一癌细胞群体为代价增加一个癌细胞群体的恶性程度。miR-9/9的功能多样性强调了研究miRNA功能的复杂性以及在相关细胞环境中对两条miRNA链进行功能研究的重要性。本文还讨论了将miR-9/9作为基于miRNA的治疗靶点的可能应用,强调需要更好地了解这些miRNA的功能特性,并开发针对特定细胞群体的安全递送方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/5945517/cb004e31b8c6/oncotarget-09-20838-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/5945517/a09edc9abad7/oncotarget-09-20838-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/5945517/75589138a577/oncotarget-09-20838-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/5945517/91c3f070c8a5/oncotarget-09-20838-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/5945517/36d3ac4a309d/oncotarget-09-20838-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/5945517/2b01887df376/oncotarget-09-20838-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/5945517/cb004e31b8c6/oncotarget-09-20838-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/5945517/a09edc9abad7/oncotarget-09-20838-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/5945517/75589138a577/oncotarget-09-20838-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/5945517/91c3f070c8a5/oncotarget-09-20838-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/5945517/36d3ac4a309d/oncotarget-09-20838-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/5945517/2b01887df376/oncotarget-09-20838-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bb9/5945517/cb004e31b8c6/oncotarget-09-20838-g006.jpg

相似文献

1
The versatile nature of miR-9/9 in human cancer.miR-9/9在人类癌症中的多功能特性。
Oncotarget. 2018 Apr 17;9(29):20838-20854. doi: 10.18632/oncotarget.24889.
2
miRNA and cancer; computational and experimental approaches.微小RNA与癌症;计算方法和实验方法
Curr Pharm Biotechnol. 2014;15(5):429. doi: 10.2174/138920101505140828161335.
3
The Oncogenic and Tumor Suppressive Long Non-Coding RNA-microRNA-Messenger RNA Regulatory Axes Identified by Analyzing Multiple Platform Omics Data from Cr(VI)-Transformed Cells and Their Implications in Lung Cancer.通过分析六价铬转化细胞的多平台组学数据鉴定出的致癌和抑癌长链非编码RNA-微小RNA-信使RNA调控轴及其在肺癌中的意义
Biomedicines. 2022 Sep 20;10(10):2334. doi: 10.3390/biomedicines10102334.
4
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.全球 microRNA 表达特征分析揭示 miR-145 在转移性结直肠癌中的致癌潜能。
BMC Cancer. 2009 Oct 20;9:374. doi: 10.1186/1471-2407-9-374.
5
Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.分泌型乳腺肿瘤间质液 microRNAs 及其靶基因与三阴性乳腺癌、肿瘤分级和免疫浸润相关。
Breast Cancer Res. 2020 Jun 30;22(1):73. doi: 10.1186/s13058-020-01295-6.
6
Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.miRNAs 对人类结直肠发生和转移发展中的调控网络和途径的影响。
BMC Genomics. 2013 Aug 29;14:589. doi: 10.1186/1471-2164-14-589.
7
Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and miR-155.解析 miRNA 为基础的癌症疗法的前景与挑战:miR-21、miR-34 和 miR-155 的最新研究进展
Int J Med Sci. 2024 Oct 28;21(14):2781-2798. doi: 10.7150/ijms.102123. eCollection 2024.
8
DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.DNA甲基化导致12种癌症相关微小RNA的失调及乳腺癌进展。
Gene. 2017 Mar 10;604:1-8. doi: 10.1016/j.gene.2016.12.018. Epub 2016 Dec 18.
9
SIV Infection Regulates Compartmentalization of Circulating Blood Plasma miRNAs within Extracellular Vesicles (EVs) and Extracellular Condensates (ECs) and Decreases EV-Associated miRNA-128.SIV 感染调节循环血浆 miRNA 在细胞外囊泡(EVs)和细胞外凝聚物(ECs)中的区室化,并降低 EV 相关 miRNA-128。
Viruses. 2023 Feb 24;15(3):622. doi: 10.3390/v15030622.
10
Double-edged sword role of miRNA-633 and miRNA-181 in human cancers.miRNA - 633和miRNA - 181在人类癌症中的双刃剑作用。
Pathol Res Pract. 2023 Aug;248:154701. doi: 10.1016/j.prp.2023.154701. Epub 2023 Jul 20.

引用本文的文献

1
NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2.NANOG 通过调控 MIR9-2 来控制睾丸生殖细胞肿瘤干细胞特性。
Stem Cell Res Ther. 2024 May 1;15(1):128. doi: 10.1186/s13287-024-03724-1.
2
Use of microRNAs as Diagnostic, Prognostic, and Therapeutic Tools for Glioblastoma.微小RNA作为胶质母细胞瘤的诊断、预后和治疗工具的应用
Int J Mol Sci. 2024 Feb 20;25(5):2464. doi: 10.3390/ijms25052464.
3
MicroRNA Expression Profile in Bone Marrow and Lymph Nodes in B-Cell Lymphomas.骨髓和淋巴结中 B 细胞淋巴瘤的 microRNA 表达谱。

本文引用的文献

1
MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts.微小RNA与急性髓系白血病:治疗意义及新观点
Blood. 2017 Sep 14;130(11):1290-1301. doi: 10.1182/blood-2016-10-697698. Epub 2017 Jul 27.
2
miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1.微小RNA-9通过靶向ABCB1调节慢性粒细胞白血病的多药耐药性。
Oncol Rep. 2017 Apr;37(4):2193-2200. doi: 10.3892/or.2017.5464. Epub 2017 Feb 17.
3
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.
Int J Mol Sci. 2023 Oct 11;24(20):15082. doi: 10.3390/ijms242015082.
4
EBV and 1q Gains Affect Gene and miRNA Expression in Burkitt Lymphoma.EB病毒和1号染色体长臂增益影响伯基特淋巴瘤中的基因和微小RNA表达。
Viruses. 2023 Aug 25;15(9):1808. doi: 10.3390/v15091808.
5
MicroRNA 9 Is a Regulator of Endothelial to Mesenchymal Transition in Diabetic Retinopathy.微小 RNA9 是糖尿病视网膜病变中内皮到间充质转化的调节因子。
Invest Ophthalmol Vis Sci. 2023 Jun 1;64(7):13. doi: 10.1167/iovs.64.7.13.
6
Investigating miR-9 as a mediator in laryngeal cancer health disparities.研究miR-9作为喉癌健康差异的介导因子。
Front Oncol. 2023 Apr 4;13:1096882. doi: 10.3389/fonc.2023.1096882. eCollection 2023.
7
Expression and molecular regulation of non-coding RNAs in HPV-positive head and neck squamous cell carcinoma.人乳头瘤病毒阳性头颈部鳞状细胞癌中非编码RNA的表达及分子调控
Front Oncol. 2023 Mar 29;13:1122982. doi: 10.3389/fonc.2023.1122982. eCollection 2023.
8
An miRNA Signature Predicts Grading of Pancreatic Neuroendocrine Neoplasms.miRNA 特征可预测胰腺神经内分泌肿瘤的分级。
Cancer Genomics Proteomics. 2023 Mar-Apr;20(2):154-164. doi: 10.21873/cgp.20370.
9
Inhibition of the epigenetically activated miR-483-5p/IGF-2 pathway results in rapid loss of meningioma tumor cell viability.表观遗传激活的 miR-483-5p/IGF-2 通路的抑制导致脑膜瘤肿瘤细胞活力迅速丧失。
J Neurooncol. 2023 Mar;162(1):109-118. doi: 10.1007/s11060-023-04264-z. Epub 2023 Feb 21.
10
Extra-Cellular Vesicles Derived from Thyroid Cancer Cells Promote the Epithelial to Mesenchymal Transition (EMT) and the Transfer of Malignant Phenotypes through Immune Mediated Mechanisms.甲状腺癌细胞来源的细胞外囊泡通过免疫介导机制促进上皮间质转化(EMT)和恶性表型转移。
Int J Mol Sci. 2023 Feb 1;24(3):2754. doi: 10.3390/ijms24032754.
微小 RNA 治疗学:癌症和其他疾病治疗新时代的到来。
Nat Rev Drug Discov. 2017 Mar;16(3):203-222. doi: 10.1038/nrd.2016.246. Epub 2017 Feb 17.
4
An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.一种综合方法确定头颈部鳞状细胞癌局部复发的介质。
Clin Cancer Res. 2017 Jul 15;23(14):3769-3780. doi: 10.1158/1078-0432.CCR-16-2814. Epub 2017 Feb 7.
5
LncRNA Taurine-Upregulated Gene 1 Promotes Cell Proliferation by Inhibiting MicroRNA-9 in MCF-7 Cells.长链非编码RNA牛磺酸上调基因1通过抑制MCF-7细胞中的微小RNA-9促进细胞增殖。
J Breast Cancer. 2016 Dec;19(4):349-357. doi: 10.4048/jbc.2016.19.4.349. Epub 2016 Dec 23.
6
Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.外泌体介导的miR-9递送诱导人乳腺成纤维细胞产生癌症相关的成纤维细胞样特性。
Cell Death Dis. 2016 Jul 28;7(7):e2312. doi: 10.1038/cddis.2016.224.
7
High expression of miR-9 in CD133 glioblastoma cells in chemoresistance to temozolomide.miR-9在对替莫唑胺具有化学抗性的CD133胶质母细胞瘤细胞中高表达。
J Cancer Stem Cell Res. 2015;3. doi: 10.14343/JCSCR.2015.3e1003. Epub 2015 Feb 27.
8
A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer.一组微小RNA、它们的基因和蛋白质靶点以及基质基因可区分早发性与晚发性雌激素受体阳性乳腺癌。
PLoS One. 2016 May 6;11(5):e0154325. doi: 10.1371/journal.pone.0154325. eCollection 2016.
9
The Wnt signaling pathway in cancer.癌症中的Wnt信号通路。
Crit Rev Oncol Hematol. 2016 Mar;99:141-9. doi: 10.1016/j.critrevonc.2015.12.005. Epub 2015 Dec 24.
10
Breast cancer intrinsic subtype classification, clinical use and future trends.乳腺癌内在亚型分类、临床应用及未来趋势。
Am J Cancer Res. 2015 Sep 15;5(10):2929-43. eCollection 2015.